In vitro As well as in vivo evidence showing intensive hepatic metabolism of bosentan indicates that liver impairment could significantly raise publicity to bosentan. Bosentan and Ro forty eight-5033 are already proven to be substrates in the human organic and natural anion transporting polypepti